Skip Nav Destination
Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia
Risk-adapted BEACOPP regimen can reduce the cumulative dose of chemotherapy for standard and high-risk Hodgkin lymphoma with no impairment of outcome
Molecular relapse in adult standard-risk ALL patients detected by prospective MRD monitoring during and after maintenance treatment: data from the GMALL 06/99 and 07/03 trials
Identification of a novel chromosome region, 13q21.33-q22.2, for susceptibility genes in familial chronic lymphocytic leukemia
Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG)
Prophylactic human granulocyte colony-stimulating factor after induction therapy in pediatric acute myeloid leukemia
Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study
Somatic revertant mosaicism in a patient with leukocyte adhesion deficiency type 1
Continuous delivery of human type I interferons (α/β) has significant activity against acute myeloid leukemia cells in vitro and in a xenograft model
Comparative single-institute analysis of cord blood transplantation from unrelated donors with bone marrow or peripheral blood stem-cell transplants from related donors in adult patients with hematologic malignancies after myeloablative conditioning regimen
Issue Archive
February 1 2007
In this Issue
Table of Contents
INSIDE BLOOD
BLOOD WORK
PERSPECTIVES
REVIEW ARTICLES
REVIEWS IN TRANSLATIONAL HEMATOLOGY
CHEMOKINES, CYTOKINES, AND INTERLEUKINS
CLINICAL TRIALS AND OBSERVATIONS
Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia
Clinical Trials & Observations
Albert Moghrabi,Donna E. Levy,Barbara Asselin,Ronald Barr,Luis Clavell,Craig Hurwitz,Yvan Samson,Marshall Schorin,Virginia K. Dalton,Steven E. Lipshultz,Donna S. Neuberg,Richard D. Gelber,Harvey J. Cohen,Stephen E. Sallan,Lewis B. Silverman
Risk-adapted BEACOPP regimen can reduce the cumulative dose of chemotherapy for standard and high-risk Hodgkin lymphoma with no impairment of outcome
Clinical Trials & Observations
Eldad J. Dann,Rachel Bar-Shalom,Ada Tamir,Nissim Haim,Menachem Ben-Shachar,Irit Avivi,Tzila Zuckerman,Mark Kirschbaum,Odelia Goor,Diana Libster,Jacob M. Rowe,Ron Epelbaum
Molecular relapse in adult standard-risk ALL patients detected by prospective MRD monitoring during and after maintenance treatment: data from the GMALL 06/99 and 07/03 trials
Clinical Trials & Observations
Thorsten Raff,Nicola Gökbuget,Silke Lüschen,Regina Reutzel,Matthias Ritgen,Sebastian Irmer,Sebastian Böttcher,Heinz-August Horst,Michael Kneba,Dieter Hoelzer,Monika Brüggemann,for the GMALL Study Group
Identification of a novel chromosome region, 13q21.33-q22.2, for susceptibility genes in familial chronic lymphocytic leukemia
Clinical Trials & Observations
David Ng,Ousmane Toure,Ming-Hui Wei,Diane C. Arthur,Fatima Abbasi,Laura Fontaine,Gerald E. Marti,Joseph F. Fraumeni, Jr,Lynn R. Goldin,Neil Caporaso,Jorge R. Toro
Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG)
Clinical Trials & Observations
Kirk R. Schultz,D. Jeanette Pullen,Harland N. Sather,Jonathan J. Shuster,Meenakshi Devidas,Michael J. Borowitz,Andrew J. Carroll,Nyla A. Heerema,Jeffrey E. Rubnitz,Mignon L. Loh,Elizabeth A. Raetz,Naomi J. Winick,Stephen P. Hunger,William L. Carroll,Paul S. Gaynon,Bruce M. Camitta
Prophylactic human granulocyte colony-stimulating factor after induction therapy in pediatric acute myeloid leukemia
Clinical Trials & Observations
Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study
Clinical Trials & Observations
Adele K. Fielding,Susan M. Richards,Rajesh Chopra,Hillard M. Lazarus,Mark R. Litzow,Georgina Buck,I. Jill Durrant,Selina M. Luger,David I. Marks,Ian M. Franklin,Andrew K. McMillan,Martin S. Tallman,Jacob M. Rowe,Anthony H. Goldstone,Medical Research Council of the United Kingdom Adult ALL Working Party and the Eastern Cooperative Oncology Group
HEMATOPOIESIS
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
IMMUNOBIOLOGY
Human T-cell leukemia virus type-1 Tax oncoprotein regulates G-protein signaling
Jean-Claude Twizere,Jean-Yves Springael,Mathieu Boxus,Arsène Burny,Franck Dequiedt,Jean-François Dewulf,Julie Duchateau,Daniel Portetelle,Patrice Urbain,Carine Van Lint,Patrick L. Green,Renaud Mahieux,Marc Parmentier,Luc Willems,Richard Kettmann
Cancer-testis antigens are commonly expressed in multiple myeloma and induce systemic immunity following allogeneic stem cell transplantation
Djordje Atanackovic,Julia Arfsten,Yanran Cao,Sacha Gnjatic,Frank Schnieders,Katrin Bartels,Georgia Schilling,Christiane Faltz,Christine Wolschke,Judith Dierlamm,Gerd Ritter,Thomas Eiermann,Dieter Kurt Hossfeld,Axel R. Zander,Achim A. Jungbluth,Lloyd J. Old,Carsten Bokemeyer,Nicolaus Kröger
Somatic revertant mosaicism in a patient with leukocyte adhesion deficiency type 1
Clinical Trials & Observations
Brief Report
Yumi Tone,Taizo Wada,Fumie Shibata,Tomoko Toma,Yoko Hashida,Yoshihito Kasahara,Shoichi Koizumi,Akihiro Yachie
NEOPLASIA
Engineered anti-CD70 antibody with multiple effector functions exhibits in vitro and in vivo antitumor activities
Julie A. McEarchern,Ezogelin Oflazoglu,Leigh Francisco,Charlotte F. McDonagh,Kristine A. Gordon,Ivan Stone,Kerry Klussman,Eileen Turcott,Nico van Rooijen,Paul Carter,Iqbal S. Grewal,Alan F. Wahl,Che-Leung Law
Bcr-Abl signaling through the PI-3/S6 kinase pathway inhibits nuclear translocation of the transcription factor Bach2, which represses the antiapoptotic factor heme oxygenase-1
Chikashi Yoshida,Fumiko Yoshida,Daniel E. Sears,Stephen M. Hart,Dai Ikebe,Akihiko Muto,Subham Basu,Kazuhiko Igarashi,Junia V. Melo
Targeting mitochondrial factor Smac/DIABLO as therapy for multiple myeloma (MM)
Dharminder Chauhan,Paola Neri,Mugdha Velankar,Klaus Podar,Teru Hideshima,Mariateresa Fulciniti,Pierfrancesco Tassone,Noopur Raje,Constantine Mitsiades,Nicholas Mitsiades,Paul Richardson,Leigh Zawel,Mary Tran,Nikhil Munshi,Kenneth C. Anderson
Tumor suppressor p16 methylation in multiple myeloma: biological and clinical implications
Natalia Gonzalez-Paz,Wee J. Chng,Rebecca F. McClure,Emily Blood,Martin M. Oken,Brian Van Ness,C. David James,Paul J. Kurtin,Kimberly Henderson,Gregory J. Ahmann,Morie Gertz,Martha Lacy,Angela Dispenzieri,Philip R. Greipp,Rafael Fonseca
Continuous delivery of human type I interferons (α/β) has significant activity against acute myeloid leukemia cells in vitro and in a xenograft model
Brief Report
Reuben Benjamin,Asim Khwaja,Nalini Singh,Jenny McIntosh,Anthony Meager,Meenu Wadhwa,Christian Streck,Catherine Ng,Andrew M. Davidoff,Amit C. Nathwani
PHAGOCYTES
RED CELLS
STEM CELLS IN HEMATOLOGY
TRANSPLANTATION
Monitoring of the JAK2-V617F mutation by highly sensitive quantitative real-time PCR after allogeneic stem cell transplantation in patients with myelofibrosis
Nicolaus Kröger,Anita Badbaran,Ernst Holler,Joachim Hahn,Guido Kobbe,Martin Bornhäuser,Andreas Reiter,Tatjana Zabelina,Axel R. Zander,Boris Fehse
Comparative single-institute analysis of cord blood transplantation from unrelated donors with bone marrow or peripheral blood stem-cell transplants from related donors in adult patients with hematologic malignancies after myeloablative conditioning regimen
Clinical Trials & Observations
Satoshi Takahashi,Jun Ooi,Akira Tomonari,Takaaki Konuma,Nobuhiro Tsukada,Maki Oiwa-Monna,Kenji Fukuno,Michihiro Uchiyama,Kashiya Takasugi,Tohru Iseki,Arinobu Tojo,Takuhiro Yamaguchi,Shigetaka Asano
CORRESPONDENCE
High frequency of the JAK2 V617F mutation in patients with thrombocytosis (platelet count > 600 × 109/L) and ringed sideroblasts more than 15% considered as MDS/MPD, unclassifiable
Norbert Gattermann,Johan Billiet,Ralf Kronenwett,Esther Zipperer,Ulrich Germing,Friedel Nollet,Arnold Criel,Dominik Selleslag
-
Cover Image
Cover Image
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkAdvertising
- PDF Icon PDF LinkEditorial Board
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals